Skip to content

A Clinical study on Rheumatoid Arthritis and its management with Vatari Guggulu and Guduchi satwa

A comparative clinical study on sero-positive and sero-negative Rheumatoid arthritis w.s.r to Amavata and its management with Vatari Guggulu and Guduchi satwa - NIL

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057478
Enrollment
100
Registered
2023-09-12
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

None listed

Sponsors

Prof Dr Simadri Bhusan Nayak
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with more than normal RA factor(20 IU/ml) Patientsage between 25-60 years of both sexes Patients having clinical features of Rheumatoid Arthritis

Exclusion criteria

Exclusion criteria: Patients having psoriatic arthritis, ankylosing spondylitis, systemic sclerosis, tuberculosis, HIV and carcinogenic growth in body. Patients having anemia due to rheumatoid arthritis.

Design outcomes

Primary

MeasureTime frame
Use of Vatari Guggul Guduchi Satwa subside clinical manifestation of RA sero positive can change into seronegative Timepoint: 3 months

Secondary

MeasureTime frame
Use of Vatari Guggul Guduchi Satwa subside clinical manifestation of RA sero positive can not change into seronegative.Timepoint: 3 months

Countries

India

Contacts

Public ContactProf. Dr. PK Panda

Govt Ayurvedic College and Hospital Balangir

drpkpandanidan@gmail.com9437150643

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026